Chris Murphy is the Chief Executive Officer of ElevateBio and a member of its Board of Directors. Chris brings more than 35 years of leadership, operational, and commercial experience across biopharmaceutical and manufacturing sectors.
by
Bhakti has more than 20 years of experience in biotech, consulting, and financial services including corporate finance, business development, strategy, and business process re-engineering. Bhakti joined ElevateBio as one of earliest employees and has been leading the finance team since 2018.
Catherine Hu joined ElevateBio in 2021 to lead the Company’s corporate affairs and investor relations functions. Prior to ElevateBio, Catherine led investor relations, corporate affairs, and patient advocacy functions at Scholar Rock, Inc. and was part of the investor relations team at Alexion Pharmaceuticals.
Katie Jorgensen joined ElevateBio in 2021 and as Site Head at BaseCamp, she is responsible for supply chain, facilities, technical operations, manufacturing, and program management supporting strategic contracts and valued partnerships bringing innovative cell and gene therapies to patients. Previously, she was the Company’s VP, Commercial Operations and CMC Program Management.
Missy has more than 15 years of experience in operations and people strategies. As a strategic thought partner to the leadership team, she identifies areas for operational improvement, provides insight and analysis on company strategy and operations, and ensures a continued focus on top priorities across the company.
Larry has more than 20 years of leadership experience and deep technical expertise, with proven success in building and scaling commercial teams, driving revenue growth, and establishing global partnerships. Currently, Larry is the Chief Commercial Officer at ElevateBio where he leads commercial strategy to accelerate revenue growth by expanding partnerships across ElevateBio.
Katherine has over 20 years of experience in biomanufacturing operations including multiple new facility startups. She currently serves as Site Head, BaseCamp Pittsburgh and is responsible for supply chain, facilities, technical operations, manufacturing, and program management.
Michael has spent the last twenty years in biotechnology building, leading and motivating process development and manufacturing teams to support clinical programs from early development to late-stage clinical trials. Currently, Michael is the Chief Technology Officer at ElevateBio and is responsible for it’s technology offerings, including cell therapy, LentiPeakTM platform, and process development.
Amy is the Chief Scientific Officer of ElevateBio. She has more than 20 years of scientific leadership and expertise with an extensive background in genetic medicine, neuroscience, drug development, and scientific strategy.
David Hallal is a 30-year veteran in the biopharmaceutical industry with expertise in early-stage company building as well as operating large multinational biotech companies. He is a co-founder of ElevateBio, previously served as Chairman and CEO, and now serves as Executive Chairman on its Board of Directors. He is currently CEO of Scholar Rock.
Vikas Sinha brings more than 30 years of experience in executive finance roles in the life sciences industry. He is a co-founder of ElevateBio, previously served as CFO, and now serves as on its Board of Directors and is Chair of the Audit Comittee. He is Chief Financial Officer of Scholar Rock.
Joy A. Cavagnaro is the President and Founder of Access BIO, where she consults globally on science-based preclinical development strategies. She has over 40 years of experience in the biotechnology industry, and has served at the United States Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) and was appointed to Senior Biomedical Research Service. Dr. Cavagnaro was also the past Chair of the Regulatory Affairs Professional Society (RAPS), President of the National Capital Area Chapter of the Society of Toxicology (SOT), and recipient of the Society’s 2019 Arnold J. Lehman Award. She received her Ph.D. in Biochemistry from the University of North Carolina at Chapel Hill, followed by post-graduate work at Duke University and Boston University Medical Centers.
